Deferred Income Tax - Ryvu Therapeutics SA (WSE:RVU) - Alpha Spread
R

Ryvu Therapeutics SA
WSE:RVU

Watchlist Manager
Ryvu Therapeutics SA
WSE:RVU
Watchlist
Price: 54.1 PLN -1.64% Market Closed
Market Cap: 1.3B PLN
Have any thoughts about
Ryvu Therapeutics SA?
Write Note

Ryvu Therapeutics SA
Deferred Income Tax

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Ryvu Therapeutics SA
Deferred Income Tax Peer Comparison

Comparables:
I
IGN
M
MDB
S
SLV

Competitive Deferred Income Tax Analysis
Latest Figures & CAGR of Competitors

Company Deferred Income Tax CAGR 3Y CAGR 5Y CAGR 10Y
R
Ryvu Therapeutics SA
WSE:RVU
Deferred Income Tax
zł23k
CAGR 3-Years
-85%
CAGR 5-Years
-65%
CAGR 10-Years
N/A
I
Inno-Gene SA
WSE:IGN
Deferred Income Tax
zł203k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Medicofarma Biotech SA
WSE:MDB
Deferred Income Tax
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Selvita SA
WSE:SLV
Deferred Income Tax
zł5.6m
CAGR 3-Years
-14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Ryvu Therapeutics SA's Deferred Income Tax?
Deferred Income Tax
23k PLN

Based on the financial report for Mar 31, 2024, Ryvu Therapeutics SA's Deferred Income Tax amounts to 23k PLN.

What is Ryvu Therapeutics SA's Deferred Income Tax growth rate?
Deferred Income Tax CAGR 5Y
-65%

The average annual Deferred Income Tax growth rates for Ryvu Therapeutics SA have been -85% over the past three years , -65% over the past five years .

Back to Top